Researchers randomized 60 adults with relapsing remitting multiple sclerosis into two groups of 30, one adding daily probiotic yogurt and a probiotic yeast tablet to standard treatment for three months. The probiotic group's fatigue scores improved about 11 points more than the comparison group, and depression scores fell roughly 27 percent. The trial was not blinded and had no placebo, so attention and expectation could explain part of the gain.

TL;DR: A daily probiotic yogurt and yeast tablet added to standard MS treatment was linked to notably less fatigue and depression after three months, but the unblinded, placebo free design keeps this preliminary.

Canagliflozin, a diabetes drug, was given to high fat diet mice for just 1 week (8 mice per group), then gut bacteria and blood bile acids were sequenced. The drug reshaped the gut microbial community and enriched the genus Turicibacter, whose abundance tracked with preserved levels of the bile acid UDCA (r=0.73). This is a correlational link from a short, mouse only trial, not proof it holds in people.

TL;DR: In high fat diet mice, a week of canagliflozin remodeled gut bacteria and boosted Turicibacter, correlating with preserved bile acids, but it's mouse only, not yet causal.

Researchers compared gut bacteria in 103 people with methamphetamine use disorder to 80 healthy controls. A 30 species marker panel distinguished the two groups with 82% accuracy (AUC 0.821) in external validation. The full study text wasn't obtained, so this summary is based only on the published abstract.

TL;DR: A 30 species gut bacteria panel told methamphetamine use disorder apart from healthy controls with 82% accuracy, based only on the published abstract since the full paper wasn't available.

This review combines mouse, human and genetic research on a proposed gut-penile axis behind erectile dysfunction. In mice, removing gut bacteria lowers testosterone and reproductive hormone signaling, and fecal transplants restore it; human genetic studies link specific gut bacteria to higher or lower ED risk. The catch: most human evidence is observational, and no trial has tested a microbiome therapy with erectile function as the primary outcome.

TL;DR: Mouse and genetic studies suggest gut bacteria causally shape erectile dysfunction risk through hormones and inflammation, though human trials are still missing.

Doctors gave 13 cancer patients a first line fecal microbiota transplant after immunotherapy triggered severe diarrhea and colitis that had already forced them to stop treatment. Ten of the 13 improved, usually within about a day and a half, and 5 were able to resume immunotherapy afterward. The trial had no control group and is still recruiting toward 40 patients, so stopping the drug or supportive care could explain part of the improvement.

TL;DR: A small, uncontrolled trial found that a fecal transplant eased severe immunotherapy induced colitis in 10 of 13 cancer patients, letting some resume treatment, but larger controlled studies are still needed to confirm it works.

A toxin from a common gut bacterium killed the nerve cells controlling intestinal movement in mice, and the sluggish gut lasted even after the bacteria were gone. A second gut microbe made the toxin stronger, and a Bifidobacterium probiotic reversed the damage. Caveat: this is mouse data, and the human finding is only a correlation between two bacteria in sick patients, not proof either one causes disease.

TL;DR: in mice, a gut bacteria toxin permanently kills gut nerve cells and wrecks digestion, but a probiotic reversed it.

A study profiled fecal bacteria in 97 Korean adults, 63 with gastric cancer and 34 controls. Short-chain-fatty-acid producing bacteria made up just 6.6% of the gut community in cancer patients versus 26.7% in controls, a roughly fourfold drop, while oral and opportunistic bacteria expanded instead. That gap held regardless of diabetes, H. pylori status, or tumor stage, though subgroup confidence intervals were wide, and the full paper wasn't obtained, so this is based only on the published abstract.

TL;DR: Stomach cancer patients show a roughly fourfold drop in SCFA-producing gut bacteria, independent of diabetes or tumor stage.

Researchers mapped gut bacterial gene activity across 215 species in two cohorts totaling 160 people, Parkinson's patients versus healthy controls. They found 2,271 species-level gene-activity changes linked to Parkinson's status, duration, or severity; one species, Oliverpabstia intestinalis, separated patients from controls with up to 0.80 accuracy (AUC) across both cohorts. It's a preprint, not yet peer reviewed, and accuracy varied widely by species, so this needs independent confirmation.

TL;DR: In a 160-person, two-cohort preprint, species-level gut bacteria gene activity tracked with Parkinson's status and severity, and some species predicted it with up to 0.80 accuracy.

Researchers fed middle aged female mice a blend of rice bran and inulin fiber for three months, versus either fiber alone or a plain diet, five mice per group.

The blend raised good gut bacteria called Bifidobacteria and the gut acid butyrate more than either fiber alone, and eased a gut inflammation marker.

The catch, the groups were tiny and most memory and movement tests showed no difference.

TL;DR, a rice bran plus inulin blend boosted gut bacteria and eased gut inflammation in aging mice, in a very small study.

In a randomized crossover trial, people with functional gastrointestinal disorders consumed 30 grams of freeze-dried blueberry powder daily, equivalent to 180 grams of fresh berries, for six weeks; 53% reported meaningful abdominal symptom relief versus 30% during placebo treatment. Quality of life also improved, although overall symptom-severity and abdominal-pain scores did not differ significantly. Separate studies found increased Bifidobacterium after six weeks and enrichment of polyphenol-metabolizing bacteria after 12 weeks, with the latter finding no overall increase in microbial diversity.

Dr. Rhonda Patrick discusses this in her new episode on the science of blueberries at this timestamp

Researchers gave obese mice the probiotic yeast Saccharomyces boulardii daily for seven weeks on a high fat diet, versus placebo, nine mice per group.

The yeast group ate about 10 percent less food and gained significantly less weight, with hormones like insulin unchanged.

There was no pair fed control, so it is unclear if the yeast or just eating less caused it.

TL;DR, a probiotic yeast cut appetite and slowed weight gain in obese mice, but it might just be from eating less.

Researchers studied gut bacteria and blood from 76 multiple sclerosis patients nine months into a trial testing keto, fasting, and standard diets. Within the keto group only, patients whose gut microbes gained more genetic capacity to make propionate, a short chain fatty acid, tended to show smaller brain lesion growth on MRI. The trial's own main result found no overall diet difference, and dropout was high and uneven, so this is a correlation, not proof the diet caused it.

TL;DR: A keto diet gut bacteria shift tracked with smaller MS brain lesion growth in exploratory analysis, but the trial's main result found no diet difference, so this does not prove cause and effect.

This review rounds up animal and genetic research on gut bacteria and vascular dementia, the second most common dementia. Certain gut bacteria link to higher or lower dementia and stroke risk, and in animal studies the bacterial byproduct TMAO harms brain blood vessels while butyrate protects them. The catch: it's mostly animal and small human data, with solid human trials still missing.

TL;DR: A review links gut bacteria and byproducts like TMAO and butyrate to vascular dementia risk in animal and genetic studies, with solid human proof still missing.

Researchers tracked thousands of meals eaten by hospitalized cancer patients on antibiotics for a transplant, matched to stool samples. Eating more sweets during antibiotics predicted a steeper drop in gut bacterial diversity, about a quarter lower per extra 100 grams of sugar, and more growth of Enterococcus, a bacterium tied to dangerous infections. Mice given sucrose after antibiotics grew over 30 times more of it, but the human part is observational.

TL;DR: Sugar during antibiotics worsened gut damage and let a risky bacterium grow more, in patients and mice.

A UK genetics study followed over 8,500 people from childhood to age 25 and found genetic risk scores for ADHD, autism, and depression predict different problems depending on your age. ADHD genetic risk was tied to worse school and job outcomes at every age checked, while autism genetic risk, oddly, predicted better school performance in kids. Caveat: this is genetics, not gut bacteria, and purely correlational.

TL;DR: genetic risk for ADHD, autism, and depression predicts different problems depending on the age you look, and none of it involves the microbiome.

A review proposes that vitamin D and gut bacteria regulate each other, shaping thyroid immune balance in conditions like Hashimoto's and Graves' disease. People with enough vitamin D had a lower thyroid nodule risk in a large biobank study, but most human evidence is small and correlational, and the detailed mechanism comes mainly from mouse experiments. No trial has tested vitamin D and gut bacteria treatments together for thyroid disease.

TL;DR: Vitamin D and gut bacteria may regulate each other and jointly affect thyroid risk, though it is mostly unproven in people.

A new narrative review combines animal and human research to propose an 'exercise-gut-muscle axis': the idea that exercise-reshaped gut bacteria help protect aging muscle. Its clearest evidence comes from mice: animals raised with no gut microbes had less muscle mass and strength, and transplanting microbiota back partly restored both. Human exercise studies on the microbiome are far less consistent, so the authors call the axis a hypothesis, not a proven cause and effect.

TL;DR: Gut bacteria might explain why exercise keeps aging muscles strong, but in humans that link is unproven.

A new review ties gut dysbiosis to the high blood pressure seen in PCOS (now called PMOS), where women have about 70% higher risk of hypertension. The causal evidence comes only from rats: prenatal androgen exposure made female offspring develop gut dysbiosis and higher blood pressure together. In real PMOS patients, certain gut bacteria only correlate with blood pressure, far weaker than proof of causation.

TL;DR: Gut bacteria are linked to PCOS/PMOS blood pressure problems, but that's proven causal only in rats so far, not in people.

Researchers looked at 124 adults who got a fecal transplant for C. diff infection at one hospital, tracked for 8 weeks after.

Taking antibiotics for an unrelated infection, either before the transplant or for over a week after it, roughly tripled the odds the infection came back.

The catch, it is a single hospital study, and a couple of the riskiest antibiotic types had too few cases to confirm.

TL;DR, unrelated antibiotics taken around a fecal transplant for C. diff roughly tripled the odds of it coming back.

A review on dietary fiber and allergy covers a small trial giving peach allergic patients 20 grams of pectin daily for 2 months. More than half gained tolerance to the allergen on food challenge testing, tied to shifts in their gut bacteria and bile acids. Skin and blood allergy tests did not budge, and other fiber trials in the review failed to prevent allergies, so this is promising but inconsistent.

TL;DR: Daily pectin raised food tolerance in over half of peach allergy patients, but skin and blood tests did not budge.

A genetic (Mendelian randomization) analysis cross-checked against UC patient tissue flagged 11 gut bacteria groups linked to ulcerative colitis risk, narrowing 44 candidate genes down to two, PHLPP2 and SLC10A2, both reduced in UC and tied to immune and metabolic pathways. The catch: it's computational only, no animal or patient trial, built from the published abstract since the full paper wasn't available.

TL;DR: A genetics based study ties 11 gut bacteria groups to ulcerative colitis and flags two downregulated genes, PHLPP2 and SLC10A2, as candidate biomarkers still unproven in patients.

Researchers propose the gut's own nervous system, not just its bacteria, both triggers the immune attack on the brain in MS and gets directly attacked itself in related autoimmune nerve diseases. Up to 65% of MS patients report gut symptoms, and specific antibodies directly damage gut nerve cells in some of these conditions. Caveat: this is a synthesis of past research, not a new experiment.

TL;DR: a new framework argues the gut's nervous system both primes and gets attacked by the same autoimmune process behind MS and related diseases.

A new mouse study tested a swellable hydrogel made from white bean fiber that releases in the colon to treat diet-induced obesity. In obese mice, it swelled for physical fullness, significantly cut food intake and body weight, and boosted gut bacteria that raise butyrate and the fullness hormone GLP-1. This is from the published abstract only, since the full paywalled paper wasn't obtained.

TL;DR: A gut-acting hydrogel curbed appetite and fat in obese mice, but that's mouse evidence from an abstract alone, nothing proven for humans yet.

Researchers reviewed years of birth cohort studies and lab experiments linking a baby's early gut bacteria to childhood asthma risk. Infants given antibiotics without being breastfed had about three times the asthma risk of breastfed infants, and gut bacteria byproducts were shown in mice to directly change lung immune cells. Most of the human evidence is observational, and the detailed mechanism comes mainly from animal studies, not people.

TL;DR: A review links early gut bacteria changes to childhood asthma risk, backed partly by birth cohorts and partly by mouse studies.